Cell death inducing agent for cells having BRAF gene mutation, agent for inhibiting proliferation of said cells and pharmaceutical composition for treating patient suffering from effects of abnormal proliferation of said cells
The present invention induces cell death and/or inhibits cell proliferation for cells having a mutation in the BRAF gene. The present invention includes, as an active ingredient, a drug inhibiting GST-π.